Catalyst Wire Dossier Catalyst Wire Dossier

XATMEP

Methotrexate · Azurity Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XATMEP, covering 2017-04-25 to 2018-03-15. Get the full timeline:

Most recent: FDA Approved: XATMEP — Supplemental Application (Azurity Pharmaceuticals, Inc.)

See pricing